A randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthma. [electronic resource]
Producer: 20170306Description: 157-164 p. digitalISSN:- 1539-6304
- Adult
- Anti-Asthmatic Agents -- therapeutic use
- Anti-Inflammatory Agents -- therapeutic use
- Asthma -- drug therapy
- Benzamides -- therapeutic use
- Cross-Over Studies
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Fluticasone -- therapeutic use
- Forced Expiratory Volume
- Humans
- Male
- Middle Aged
- Pyrimidines -- therapeutic use
- Receptors, Immunologic -- antagonists & inhibitors
- Receptors, Prostaglandin -- antagonists & inhibitors
- Treatment Outcome
- Vital Capacity
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.